Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is PTrana Meditama Metropolitan Tbk Current Ratio?
PTrana Meditama Metropolitan TbkISX:SAME -0.65%79 Current Ratio is 0.54 as of Mar. 2026, which is 48% below its 10-year median of 1.04. GuruFocus rates ISX:SAME with a GF Score™ of 79/100 and a GF Value™ of Rp355.08 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 683 Healthcare Providers & Services companies, PTrana Meditama Metropolitan Tbk ranks worse than 88.73% on this metric.
PTrana Meditama Metropolitan Tbk has a current ratio of 0.54. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If PTrana Meditama Metropolitan Tbk has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
The historical rank and industry rank for PTrana Meditama Metropolitan Tbk's Current Ratio or its related term are showing as below:
ISX:SAME'
s Current Ratio Range Over the Past 10 Years
Min: 0.43 Med: 1.04 Max: 6.83
Current: 0.54
During the past 13 years, PTrana Meditama Metropolitan Tbk's highest Current Ratio was 6.83. The lowest was 0.43. And the median was 1.04.
ISX:SAME's Current Ratio is ranked worse than 88.73% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs ISX:SAME: 0.54
PTrana Meditama Metropolitan Tbk (ISX:SAME) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
PTrana Meditama Metropolitan Tbk Current Ratio Related Terms
PTrana Meditama Metropolitan Tbk Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PTrana Meditama Metropolitan Tbk Current Ratio Chart
ISX:SAME vs HCA, THC, DVA: Current Ratio Comparison
For the Medical Care Facilities subindustry, PTrana Meditama Metropolitan Tbk's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PTrana Meditama Metropolitan Tbk Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PTrana Meditama Metropolitan Tbk's Current Ratio distribution charts can be found below:
* The bar in red indicates where PTrana Meditama Metropolitan Tbk's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PTrana Meditama Metropolitan Tbk (ISX:SAME) has a Current Ratio of 0.54 as of Mar. 2026. This is 48% below median its historical median of 1.04. Over the past decade, PTrana Meditama Metropolitan Tbk's Current Ratio has ranged from 0.43 to 6.83. According to the industry distribution chart, PTrana Meditama Metropolitan Tbk ranks #606 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 88.7%.
Is PTrana Meditama Metropolitan Tbk's Current Ratio too high?
PTrana Meditama Metropolitan Tbk's current Current Ratio of 0.54 is 48% below median its 10-year median of 1.04. Over the past 10 years, this metric has ranged from a low of 0.43 to a high of 6.83. The Healthcare Providers & Services industry median Current Ratio is 1.47. PTrana Meditama Metropolitan Tbk's value of 0.54 is 63.3% below this industry median. Based on the distribution chart, PTrana Meditama Metropolitan Tbk ranks #606 out of 683 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, PTrana Meditama Metropolitan Tbk has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PTrana Meditama Metropolitan Tbk's Current Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PTrana Meditama Metropolitan Tbk ranks #606 out of 683 companies for Current Ratio. This places PTrana Meditama Metropolitan Tbk in the lower half of its industry. The industry median Current Ratio is 1.47. PTrana Meditama Metropolitan Tbk's value of 0.54 is 63.3% below this benchmark. Historically, PTrana Meditama Metropolitan Tbk's own Current Ratio has ranged from 0.43 to 6.83 over the past decade. While the company's 10-year median is 1.04 vs. the industry median of 1.47, PTrana Meditama Metropolitan Tbk has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.47, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PTrana Meditama Metropolitan Tbk's current Current Ratio of 0.54 is 63.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PTrana Meditama Metropolitan Tbk's current Current Ratio is 0.54, which is 48% below median its own 10-year median of 1.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PTrana Meditama Metropolitan Tbk stock overvalued right now?
Based on GuruFocus' analysis, PTrana Meditama Metropolitan Tbk (ISX:SAME) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp355.08, compared to a current price of Rp306.00 — trading 13.8% below its estimated fair value. The current Current Ratio is 0.54, which is 48% below median its 10-year median of 1.04 and 63.3% below the Healthcare Providers & Services industry median of 1.47. PTrana Meditama Metropolitan Tbk's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For PTrana Meditama Metropolitan Tbk (ISX:SAME), the current Current Ratio is 0.54 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PTrana Meditama Metropolitan Tbk (ISX:SAME) Overvalued in 2026?
Based on GuruFocus' analysis, PTrana Meditama Metropolitan Tbk stock appears to be undervalued.
The current stock price of Rp306.00 is trading 13.8% below its estimated GF Value™ of Rp355.08.
GuruFocus considers PTrana Meditama Metropolitan Tbk to be Modestly Undervalued.
Key valuation signals for ISX:SAME:
Current Ratio: 0.54 (48% below median its 10-year median of 1.04)
GF Value™: Rp355.08 vs. price of Rp306.00 (13.8% below fair value)
Industry Position: 63.3% below the Healthcare Providers & Services median (#606 of 683)
No single metric tells the full story. See the ISX:SAME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PTrana Meditama Metropolitan Tbk Business Description
PT Sarana Meditama Metropolitan Tbk is engaged in managing hospitals. Its hospitals are operated under the brand name Omni Hospital. The company manages and evaluates its business based on its geographic location consisting of Omni Pulomas, Omni Alam Sutera, Omni Cikarang, OMNI Pekayon, and others. It operates in Banten, DKI Jakarta, and West Java.
79GF Score
Get the complete analysis for ISX:SAME
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SAME has been successfully added to your 
